We investigated the antiviral activity of nanosized copper(I) iodide (CuI) particles having an average size of 160 nm. CuI particles showed aqueous stability and generated hydroxyl radicals, which were probably derived from monovalent copper (Cu ؉ ). We confirmed that CuI particles showed antiviral activity against an influenza A virus of swine origin (pandemic [H1N1] 2009) by plaque titration assay. The virus titer decreased in a dose-dependent manner upon incubation with CuI particles, with the 50% effective concentration being approximately 17 g/ml after exposure for 60 min. SDS-PAGE analysis confirmed the inactivation of the virus due to the degradation of viral proteins such as hemagglutinin and neuraminidase by CuI. Electron spin resonance (ESR) spectroscopy revealed that CuI generates hydroxyl radicals in aqueous solution, and radical production was found to be blocked by the radical scavenger N-acetylcysteine. Taken together, these findings indicate that CuI particles exert antiviral activity by generating hydroxyl radicals. Thus, CuI may be a useful material for protecting against viral attacks and may be suitable for applications such as filters, face masks, protective clothing, and kitchen cloths.
I
nfluenza virus is a communicable pathogen that typically spreads through humans, birds, and swine. Although avian influenza viruses rarely infect humans, since 2003 several cases of humans infected by avian influenza (H5N1) with high lethality have been reported in Asia and the Middle East. Avian and human influenza viruses can simultaneously infect swine, occasionally resulting in the genetic hybridization of these two strains. In fact, the influenza virus of swine origin spread worldwide in the 2009 pandemic (H1N1) was a genetically hybridized mutant of swine, avian, and human influenza viruses (17) . In addition, the transmission of influenza viruses is very rapid due to the spread of worldwide transportation networks. Thus, additional measures to inhibit the spread of viral infection are urgently necessary.
To prevent viral infection, there is a strong need to develop antiviral products in addition to antibacterial products. There are few materials that have been reported to inactivate viruses. For example, titanium dioxide (TiO 2 ) is an antiviral material that has been used as a coating agent. Under UV light, TiO 2 generates hydroxyl radicals (·OH) (9) , and this results in the degradation of organic compounds. However, there are some limitations regarding the use of TiO 2 , including the requirement of UV irradiation and the degradation of the base material.
On the other hand, copper has long been used as an antibacterial material (1) , and several copper compounds have been reported to exhibit viral inactivation. Yamamoto et al. reported the inactivation of bacteriophages by copper in 1964 (25) . More recently, the inactivation of avian influenza virus by copper metal (18) and divalent copper ions (Cu 2ϩ ) (11) and the inactivation of human immunodeficiency virus (HIV) by copper ions (20) and copper oxide (2, 3) have been reported. Because copper metal and copper oxide are stable compounds, they can easily be used in antiviral applications. However, the external appearance of products treated with these materials is invariably altered because of their brown and black color.
To address this problem, we focused on another copper compound, copper(I) iodide (CuI), which is white and has greater stability in air and water than other cuprous halides, and therefore can be applied to products such as filters, face masks, protective clothing, and kitchen cloths. However, the antiviral properties of CuI have not been investigated. Generally, the characteristics of fine particles with sizes in the nanometer range differ significantly from those in bulk form. The vast increase in specific surface area by scaling down fine particles to the nanoscale markedly changes their original physical and chemical characteristics. Therefore, this study investigated the antiviral activity of nanosized CuI particles against pandemic (H1N1) 2009 influenza virus.
MATERIALS AND METHODS
Preparation of nanosized CuI particles and CuI suspension. CuI (Nihon Kagaku Sangyo Co., Ltd., Tokyo, Japan) particles having a median particle diameter (D50) of 5.84 m were pulverized in a NanoJetmizer NJ-100B (Aishin Nano Technologies Co., Ltd., Saitama, Japan), a superfine mill with a high-pressure jet stream, until the D50 reached 160 nm (see Fig. S1 in the supplemental material). These particle sizes were measured with a CILAS 1064L particle size analyzer (CILAS, Orleans, France). CuI particles then were suspended in phosphate-buffered saline (PBS; Wako Pure Chemical Industries, Ltd., Osaka, Japan) at 10 mg/ml, stirred for 15 min, and diluted to the desired concentrations with PBS.
Viruses and cells. Influenza virus A/California/07/09 (H1N1) pdm (A/H1N1pdm) was supplied by the National Institute of Infectious Dis-eases (NIID) in Japan to the Chiba University Graduate School of Medicine. Virus was propagated four times in embryonated chicken eggs, and infectious allantoic fluid then was harvested, followed by further propagation in Madin-Darby canine kidney (MDCK) cells. MDCK cells were supplied by the Bio-Medical Science Association of Japan.
MDCK cells were cultured as monolayers in minimum essential medium (MEM; MP Bio Japan K.K., Tokyo, Japan) supplemented with 10% fetal calf serum (Australian origin; Gibco, Carlsbad, CA), 1.1 g/liter sodium hydrogen carbonate (NaHCO 3 ; Wako Pure Chemical Industries, Ltd.), and 0.006% kanamycin (Wako Pure Chemical Industries, Ltd.) (22) . Kanamycin was selected in this study because it is superior to penicillin G-streptomycin in terms of antibacterial spectrum and cytotoxicity. MDCK cells were plated at a density of 1 ϫ 10 5 cells/ml in a 150-cm 2 flask and were cultured for 72 h. Cells then were washed with MEM containing 1.1 g/liter NaHCO 3 and 0.006% kanamycin (1ϫ MEM), and 1ϫ MEM was added to the flask, followed by culture at 37°C in a CO 2 incubator. After 1 h, medium was removed and 5 ml of virus suspension (10 4 PFU/ ml) was added, and this was further incubated for 1 h. The medium containing viruses was removed, and 1ϫ MEM containing 2.5 g/ml trypsin (from bovine pancreas; MP Bio Japan K.K.) was added. After incubation at 34°C for 48 h, the culture supernatant was collected by centrifugation at 5,000 rpm for 10 min and was stored at Ϫ80°C. The virus titer was determined to be 2.8 ϫ 10 6 PFU/0.1 ml by plaque formation in monolayers of MDCK cells as described below.
Virus titration by plaque assay. The plaque assay was performed as follows (22) . Ten-mg/ml CuI suspensions in PBS were prepared and were serially diluted with PBS from 1 to 1,000 g/ml. One hundred l of CuI suspension and 100 l of diluted virus suspension (approximately 10 5 PFU/0.1 ml) were mixed and incubated with shaking for 1 h at 25°C. After incubation, 800 l of soybean-casein digest with lecithin and polysorbate 80 medium (SCDLP; Wako Pure Chemical Industries, Ltd.) was added, followed by vortexing. Aliquots of supernatant were used as virus samples.
Confluent monolayers of MDCK cells in six-well tissue culture plates (Sumilon; Sumitomo Bakelite Co., Ltd., Tokyo, Japan) were prepared, and the medium was removed and washed with 3 ml of MEM. Cells were inoculated with 100 l of virus sample. After incubation for 60 min at 34°C, cells were washed with MEM and overlaid with MEM containing 1.1 g/liter NaHCO 3 , 0.01% DEAE-dextran (GE Healthcare Japan Co., Tokyo, Japan), 1 g/ml trypsin, and 0.7% noble agar (Funakoshi Co., Ltd., Tokyo, Japan). After incubation for 48 h at 34°C under 5% CO 2 in air, cells were fixed with 10% formaldehyde (Wako Pure Chemical Industries, Ltd.) in PBS for 4 h, and the agar overlay was removed by flooding with tap water. Attached cells were stained with 0.038% methylene blue (Wako Pure Chemical Industries, Ltd.), and plaques were counted and calculated.
SDS-PAGE. Concentrated virus suspension was prepared as follows. Virus stock (1.8 ϫ 10 10 PFU) was concentrated by centrifugation (21,500 ϫ g, 2.5 h) and resuspended in 2 ml of 10% glucose in PBS. A sucrose step gradient (20 and 60% glucose in PBS) was overlaid with virus suspension, followed by centrifugation (21,500 ϫ g, 2.5 h). The virus layer between 20 and 60% glucose was recovered and used as the virus sample (1.1 ϫ 10 10 PFU/ml). Twelve microliters of virus suspension (1.3 ϫ 10 8 PFU) was mixed with 12 l of CuI suspension (1 to 1,000 g/ml). Luminol chemiluminescence detection of reactive oxygen species (ROS). CuI suspensions (10 mg/ml in Milli-Q water) or the same molar concentrations of CuSO 4 ·5H 2 O were centrifuged (9,400 ϫ g, 3 min), and supernatants were passed through a polytetrafluoroethylene filter (0.2 m pore size). Samples (50 l) were placed into tubes and set in the luminometer (TK-LP400; Tokken Inc., Chiba, Japan). When measurement started, 50 l of horseradish peroxidase solution (Tokken Inc.) and 50 l of luminol solution (Tokken Inc.) were automatically added to the sample tube, and luminol chemiluminescence intensity was recorded sequentially. Hydrogen peroxide and distilled water were used as positive and negative controls, respectively.
RESULTS

Inactivation of influenza virus by CuI.
To test whether CuI shows antiviral effects, we first incubated A/H1N1pdm (10 5 PFU/0.1 ml) in CuI suspension and the virus titer was determined. Figure 1 shows the dose dependence of viral inactivation by CuI suspension in PBS from 0 to 1,000 g/ml. A/H1N1pdm was incubated with CuI for 60 min at room temperature, and virus titers were measured by plaque assay. The virus titer was decreased by incubation with CuI in a dose-dependent manner with a 50% effective concentration (EC 50 ) of approximately 17 g/ml (0.0017% [wt/ vol]). This indicates that CuI particles inactivate influenza virus.
We next analyzed whether CuI modifies viral proteins such as hemagglutinin (HA) and neuraminidase (NA). Figure 2 shows the dose-dependent differences in the SDS-PAGE patterns of proteins in influenza virus from control and CuI-treated virus. These protein bands were derived from virus, as no protein bands were observed in the samples of CuI or PBS without virus (see Fig. S2 in the supplemental material). Protein bands were wider and showed lower intensity after the treatment with 1 g/ml (lane 4) of CuI for 1 h, indicating the degradation of viral proteins by CuI.
Detection of oxygen radical formation by ESR spectroscopy. Generally, monovalent copper (Cu ϩ ) in an aqueous solution (Cu ϩ aq ) tends to be converted to metallic copper or Cu 2ϩ by a disproportionation reaction. Therefore, the valence state of copper in CuI suspension was investigated by ESR spectroscopy. As shown in Fig. 3 , the ESR spectrum of CuSO 4 ·5H 2 O solution showed bands assigned to Cu 2ϩ , with the perpendicular g value (spectroscopic splitting factor) being 2.0. The g values of the bands were assigned to mononuclear Cu 2ϩ complexes with four-oxygen ligation (23, 26) . On the other hand, no ESR bands for Cu 2ϩ were detected in the CuI suspension, indicating that most CuI exists as Cu ϩ in aqueous solution.
It has been reported that Cu ϩ in aqueous solution might behave as a catalyst in a Fenton-like reaction (16) , leading to the generation of ·OH. ESR measurement using a spin trap DMPO, which is widely used in ESR spectroscopy, was performed to investigate whether CuI generates ·OH. Figure 4 shows the ESR spectra of the 0.5 mM CuI suspension and the 0.5 mM CuSO 4 ·5H 2 O solution (Cu 2ϩ source; control). The formation of DMPO-OH adduct from DMPO through the nucleophilic addition of water in the presence of metal ions (10) was blocked in this experiment by the addition of a chelating agent, EDTA. An equal volume of EDTA (1 mM) was added to the CuI suspension, and DMPO then was added. As shown in the figure, the CuI suspension showed a typical DMPO-OH signal with four peaks between the manganese markers (15) . However, the CuSO 4 ·5H 2 O solution did not show this signal, thus suggesting that Cu ϩ is involved in ·OH generation (Fig. 4) .
Detection of ROS by luminol chemiluminescence. Luminol chemiluminescence was employed as another method for detecting ROS. In aqueous solution, luminol reacts with oxidants such as hydrogen peroxide (H 2 O 2 ) and hydroxide (OH Ϫ ), resulting in chemiluminescence emission. Therefore, the phenomenon generally is used for the detection of ROS. Figure 5 shows the chemiluminescence intensity of the luminol reaction in CuSO 4 ·5H 2 O solution or supernatant of CuI suspension. The CuI particles, which interfere with the measurement of chemiluminescence due to scattering, were removed by centrifugation and filtration. Similarly to the ESR results, there were no differences in chemiluminescence intensity between the negative control (PBS) and CuSO 4 ·5H 2 O solution, whereas a significant increase in luminol chemiluminescence was detected in the supernatant of the CuI suspension, thus confirming the generation of ROS in CuI suspension.
Inhibition of ·OH formation by NAC. The results shown in Fig. 4 and 5 confirmed ·OH generation by CuI. To examine the consistency within these observations, we tested whether the ·OH formation associated with CuI is inhibited by a radical scavenger. Figure 6 shows the ESR spectra for the 0.5 mM CuI suspension and the CuI suspension in the presence of a radical scavenger, 250 g/ml N-acetylcysteine (NAC). The ESR signal for DMPO-OH was observed in the CuI suspension, but it was scarcely detected in 
DISCUSSION
In this study, we found for the first time that nanosized CuI particles have antiviral activity. It was estimated from our data that the EC 50 of CuI particles against influenza viruses was 0.0017% (wt/vol) after treatment for 1 h. We also found that CuI particles possess the ability to generate ·OH derived from Cu ϩ (no ·OH was generated by Cu 2ϩ from CuSO 4 ·5H 2 O).
We further elucidated that ROS exert antiviral activity against influenza virus by degrading functional proteins, such as HA and NA. It is well known that ·OH oxidatively modifies proteins. It has been reported that ·OH produced covalently bound aggregate, whereas the combination of ·OH and O 2Ϫ caused extensive protein fragmentation (8) . As discussed below, Cu ϩ probably produces both ·OH and O 2Ϫ , resulting in the degradation fragment of viral proteins as shown in the SDS-PAGE analysis. Yamamoto et al. reported that viral protein modification by myeloperoxidase resulted in antiviral activity (24) . Thus, CuI appears to inactivate influenza viruses by degrading viral proteins. It has been reported that copper metal and copper oxide have antiviral activity; copper metal takes approximately 6 h to inactivate 10 4 influenza A virus particles (18) . In the case of HIV-1, the virus is surrounded by a lipid bilayer with envelope proteins, similarly to influenza viruses. The 50% inhibitory concentration of copper oxide (a mixture of 70% Cu 2 O and 30% CuO) against HIV-1 is approximately 0.3% (wt/vol) after treatment for 2 h (2, 3).
·OH is known as an ROS that induces damage in biological tissues and cells through its potent oxidation activity. There are numerous reports on virus inactivation by the photocatalytic properties of TiO 2 , which also generates ·OH by the oxidation of H 2 O (7, 12, 13, 21) . On the other hand, Cu ϩ probably participates in a Fenton-like reaction to produce ·OH from hydrogen peroxide (16) Similarly, Cu ϩ dissolved from CuI in water or Cu ϩ existing on the surface of CuI may be oxidized back to Cu 2ϩ with the subsequent formation of hydrogen peroxide via the superoxide intermediate.
Another mechanism of viral inactivation by Cu ϩ is thought to be lipid peroxidation through the following reactions (4, 14) : Cu ϩ ϩ LOOH ¡ Cu 2ϩ ϩ LO· ϩ OH Ϫ and Cu 2ϩ ϩ LOOH ¡ LOO· ϩ H ϩ .
As the envelope of influenza viruses is composed mainly of lipids, Cu ϩ may inactivate viruses by oxidizing lipids. In addition to oxidative damage by ·OH, the precise mechanisms of ·OH formation by CuI and lipid peroxide levels remain to be elucidated in future studies.
The activity of conventional TiO 2 can be increased by nanoparticle processing, but this leads to the degradation of treated organic polymers. On the other hand, CuI shows sufficient ROS generation but has less activity than the photocatalyst TiO 2 . The properties of CuI will enable it to be applied to filters, masks, protective clothing, and dishcloths by mixing with or coating on polymer base materials without any breakdown of treated materials. In fact, we have successfully coated nonwoven fabrics with CuI particles without any discoloration while maintaining antiviral activity (unpublished data).
